erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Pleural Effusion, Malignant D016066 6 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Xerostomia D014987 6 associated lipids
Pneumonia, Mycoplasma D011019 6 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Mycoplasmatales Infections D009180 6 associated lipids
Nocardia Infections D009617 6 associated lipids
Pericarditis D010493 6 associated lipids
Bronchiolitis D001988 6 associated lipids
Whooping Cough D014917 6 associated lipids
Conjunctivitis D003231 7 associated lipids
Tachycardia D013610 7 associated lipids
Stomach Diseases D013272 7 associated lipids
Bronchiectasis D001987 7 associated lipids
Femoral Fractures D005264 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Food Hypersensitivity D005512 7 associated lipids
Bone Resorption D001862 7 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Cardiac Tamponade D002305 7 associated lipids
Bacteriuria D001437 7 associated lipids
Paresthesia D010292 7 associated lipids
Nausea D009325 7 associated lipids
Folliculitis D005499 7 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Gonorrhea D006069 7 associated lipids
Corynebacterium Infections D003354 7 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Skin Diseases, Infectious D012874 7 associated lipids
Lipidoses D008064 7 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Bronchopneumonia D001996 7 associated lipids
Psychoses, Substance-Induced D011605 7 associated lipids
Chronic Disease D002908 7 associated lipids
Community-Acquired Infections D017714 8 associated lipids
Leprosy D007918 8 associated lipids
Osteolysis D010014 8 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Lymphadenitis D008199 8 associated lipids
Arthralgia D018771 8 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Pemphigoid, Bullous D010391 8 associated lipids
Heart Diseases D006331 8 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Otitis Externa D010032 8 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Constipation D003248 8 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Aydin S et al. Application of real-time PCR to determination of combined effect of antibiotics on Bacteria, Methanogenic Archaea, Archaea in anaerobic sequencing batch reactors. 2015 Water Res. pmid:25792437
Wunder DB et al. Sorption of antibiotics to biofilm. 2011 Water Res. pmid:21334040
González-Pleiter M et al. Toxicity of five antibiotics and their mixtures towards photosynthetic aquatic organisms: implications for environmental risk assessment. 2013 Water Res. pmid:23399078
Subirats J et al. Emerging contaminants and nutrients synergistically affect the spread of class 1 integron-integrase (intI1) and sul1 genes within stable streambed bacterial communities. 2018 Water Res. pmid:29573631
Fan C and He J Proliferation of antibiotic resistance genes in microbial consortia of sequencing batch reactors (SBRs) upon exposure to trace erythromycin or erythromycin-H2O. 2011 Water Res. pmid:21482429
Michael-Kordatou I et al. Erythromycin oxidation and ERY-resistant Escherichia coli inactivation in urban wastewater by sulfate radical-based oxidation process under UV-C irradiation. 2015 Water Res. pmid:26360228
Derrouiche S et al. Process design for wastewater treatment: catalytic ozonation of organic pollutants. 2013 Water Sci. Technol. pmid:24056437
Avella AC et al. Activated sludge behaviour in a batch reactor in the presence of antibiotics: study of extracellular polymeric substances. 2010 Water Sci. Technol. pmid:20555211
Aydın S et al. Inhibitory effect of erythromycin, tetracycline and sulfamethoxazole antibiotics on anaerobic treatment of a pharmaceutical wastewater. 2015 Water Sci. Technol. pmid:26038926
Yuan SF et al. Levels of six antibiotics used in China estimated by means of wastewater-based epidemiology. 2016 Water Sci. Technol. pmid:26901719
Aydın S et al. The joint acute effect of tetracycline, erythromycin and sulfamethoxazole on acetoclastic methanogens. 2015 Water Sci. Technol. pmid:25909721
Aydin S et al. Performance of anaerobic sequencing batch reactor in the treatment of pharmaceutical wastewater containing erythromycin and sulfamethoxazole mixture. 2014 Water Sci. Technol. pmid:25429450
Wang QX et al. [To inquire into the classifiable position of Streptomyces erythreus 2577]. 1986 Wei Sheng Wu Xue Bao pmid:3751016
Wang C et al. [Study of the genetic stability of expression plasmid vector pMG36e in host bacteria]. 2005 Wei Sheng Yan Jiu pmid:15952668
Nwako F Proceedings: Effect of pre-operative antibiotic regimen on development of infection after intestinal surgery. 1975 West Afr J Pharmacol Drug Res pmid:775790
Polley RF Use of erythromycin-sulfas in office practice. 1966 West Med Med J West pmid:6013699
Legionnaires' disease. 1978 West. J. Med. pmid:735046
Zechnich AD et al. Possible interactions with terfenadine or astemizole. 1994 West. J. Med. pmid:8023479
Siegel D Management of community-acquired pneumonia in outpatients. 1985 West. J. Med. pmid:3976218
Updike WS et al. Successful medical treatment of listerial brain abscess. 1990 West. J. Med. pmid:2333704
Marinella MA More on lovastatin. 1995 West. J. Med. pmid:7725700
Barrett-Connor E Current status of the treatment of syphilis. 1975 West. J. Med. pmid:1089007
Frick PA et al. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State. 1998 West. J. Med. pmid:9866434
Forquer BD and Linthicum FH Middle ear effusion in children: a report of treatment in 500 cases. 1982 West. J. Med. pmid:6184891
Spach DH et al. Rhabdomyolysis associated with lovastatin and erythromycin use. 1991 West. J. Med. pmid:2006579
Covelli HD et al. Psittacosis: clinical presentation and therapeutic observations. 1980 West. J. Med. pmid:7376661
DIPHTHERIA carriers rapidly cleared. 1953 Whats New pmid:24542774
PYODERMA responds to erythromycin ointment. 1953 Whats New pmid:24542848
ERYTHROMYCIN; a current appraisal. 1954 Whats New pmid:24543301
ERYTHROCIN in trachoma. 1954 Whats New pmid:24543306
ERYTHROMYCIN prophylaxis against ophthalmia neonatorum. 1956 Whats New pmid:24544143
Arct WA [Carpal lesion due to brucellosis]. 1970 Wiad. Lek. pmid:5482241
Rudzki S et al. [Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding]. 2006 Wiad. Lek. pmid:17209345
Gebka W et al. [Case of consumption coagulopathy during staphylococcal septicemia]. 1971 Wiad. Lek. pmid:5139150
Czambor-Ksiazek E et al. [Disorders of gastric emptying in diabetes. II. Treatment]. 1997 Wiad. Lek. pmid:9297356
Ploier R et al. [Campylobacter jejuni infections in children]. 1985 Wien Med Wochenschr pmid:3895753
Zechner G [The value of targeted antibiotic therapy based on the example of streptococcal infections with special reference to late side effects]. 1983 Wien Med Wochenschr pmid:6559004
MULLER WK [Erythromycin treatment of spinal pachy- and leptomeningitis with a contribution to the clinical picture of spinal epidural abscess]. 1958 Wien Med Wochenschr pmid:13581715
Hatzenberger H [Atypical migrating pneumonia]. 1972 Wien Med Wochenschr pmid:5079728
Lagrange PH [Round table discussion "Josamycin and macrophages: a preferred relationship]. 1988 Wien Med Wochenschr pmid:3407204
Spitzy KH [Ecological viewpoints in antibacterial chemotherapy]. 1970 Wien Med Wochenschr pmid:4918431
Rauter G [Comparative studies on antibiotic sensitivity of staphylococci and enterococci in reference to the effect of oleandomycin]. 1972 Wien Med Wochenschr pmid:4484875
Leskova R and Neumeister E [Determination of erythromycin excretion time in the milk following intramammary administration]. 1969 Wien Tierarztl Monatsschr pmid:5818871
Horn S et al. Cholestasis and liver cell damage due to hypersensitivity to erythromycin stearate--recurrence following therapy with erythromycin succinate. 1999 Wien. Klin. Wochenschr. pmid:10081126
KARPINSKI W [The use of erythromycin in pediatry]. 1955 Wien. Klin. Wochenschr. pmid:13247878
Kalenda J [New, in Austria registered specialty drugs. Aknemycin 1% compositum. Hydrophilic ointment with color paste]. 1992 Wien. Klin. Wochenschr. pmid:1355937
PROTIVINSKY R and ZELLINGER O [Therapy of mixed infection tuberculous empyema; preliminary report]. 1958 Wien. Klin. Wochenschr. pmid:13570054
Zinnecker HJ et al. [Posttraumatic infection with a lactose splitting variant of Pasteurella multocida]. 1970 Wien. Klin. Wochenschr. pmid:4998002
Zagar Z [Antimicrobial therapy and public health]. 1967 Wien. Klin. Wochenschr. pmid:5185251
Fanta D and Niebauer G [Progress in medicine in individual presentations, XI. Modern forms of therapy in acne]. 1977 Wien. Klin. Wochenschr. pmid:73259
Luger A [Syphilis diagnosis in the age of antibiotics]. 1971 Wien. Klin. Wochenschr. pmid:5559788
Breitfellner G et al. [Staphylococci in the Vienna area. Epidemiology, antibiotic sensitivity and therapeutic aspects]. 1968 Wien. Klin. Wochenschr. pmid:5188335
Assadian O et al. Prophylaxis of ophthalmia neonatorum--a nationwide survey of the current practice in Austria. 2002 Wien. Klin. Wochenschr. pmid:12238308
Breitfellner G and Neuhold R [Yearly variations of the lysotype and resistance picture of staphylococci]. 1968 Wien. Klin. Wochenschr. pmid:4232544
Rytel MW and Coonrod JD Therapy of viral, mycoplasmal and rickettsial infections. 1971 Wis. Med. J. pmid:4101370
Chusid MJ et al. Neutropenia in dysgammaglobulinemia I: remission with immunoglobulin therapy. 1981 Wis. Med. J. pmid:7281709
Larratt K et al. Sporadic cases of Legionnaires' disease in Wisconsin: epidemiologic and clinical characteristics. 1980 Wis. Med. J. pmid:7210696
Krone LV The importance of multiple antibiotic coverage for hospitalized patients when the community acquired pneumonia is Legionnaire's disease. 1998 WMJ pmid:9617308
Matsunaga H et al. Manometric evidence of improved early gastric stasis by erythromycin after pylorus-preserving pancreatoduodenectomy. 2000 World J Surg pmid:11071469
Raahave D et al. Cefotaxime i.v. versus oral neomycin-erythromycin for prophylaxis of infections after colorectal operations. 1988 World J Surg pmid:3041682
Condon RE Intestinal antisepsis: rationale and results. 1982 World J Surg pmid:7090403
Stone HH and Fabian TC Clinical comparison of antibiotic combinations in the treatment of peritonitis and related mixed aerobic-anaerobic surgical sepsis. 1980 World J Surg pmid:7233913
Attaran B et al. Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics. 2017 World J. Gastroenterol. pmid:28275296
Niv E et al. Effect of erythromycin on image quality and transit time of capsule endoscopy: a two-center study. 2008 World J. Gastroenterol. pmid:18442206
Sári R et al. Ethanol inhibits the motility of rabbit sphincter of Oddi in vitro. 2004 World J. Gastroenterol. pmid:15526367
Liu ZQ et al. Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance. 2008 World J. Gastroenterol. pmid:18777600
Leung WK et al. Effect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy. 2005 World J. Gastroenterol. pmid:16097060
Lim CH et al. Effect of DA-9701 on gastric emptying in a mouse model: assessment by ¹³C-octanoic acid breath test. 2013 World J. Gastroenterol. pmid:23885150
Jiang DP et al. Treatment of pediatric Ogilvie's syndrome with low-dose erythromycin: a case report. 2007 World J. Gastroenterol. pmid:17461506
Suchitra AD et al. Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice. 2003 World J. Gastroenterol. pmid:12679931
Ung D et al. Metabolic interactions between prokinetic agents domperidone and erythromycin: an in vitro analysis. 2009 Xenobiotica pmid:19575604
Hu J et al. Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats. 2007 Xenobiotica pmid:17614005
Salimi A et al. Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. 2016 Xenobiotica pmid:26068526
Emoto C et al. Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human. 2001 Xenobiotica pmid:11491388
Bickel MH et al. Entero-bacterial formation of cyclohexylamine in rats ingesting cyclamate. 1974 Xenobiotica pmid:4372812
Yamazaki H et al. Effects of roxithromycin, erythromycin and troleandomycin on their N-demethylation by rat and human cytochrome P450 enzymes. 1996 Xenobiotica pmid:8948090
Pasic J et al. The interaction between chronic oral slow-release theophylline and single-dose intravenous erythromycin. 1987 Xenobiotica pmid:3604256
Yamazaki H and Shimada T Formation in vitro of an inhibitory cytochrome P450 x Fe2+-metabolite complex with roxithromycin and its decladinosyl, O-dealkyl and N-demethyl metabolites in rat liver microsomes. 1998 Xenobiotica pmid:9849646
Saitoh R et al. Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats. 2007 Xenobiotica pmid:17926229
Berg-Candolfi M et al. Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N(G)-monomethyl-L-arginine on the hepatic suppression. 1996 Xenobiotica pmid:9173679
Villa P et al. Erythromycin toxicity in primary cultures of rat hepatocytes. 1985 Aug-Sep Xenobiotica pmid:4072263
Ward KW et al. Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions. 2009 Xenobiotica pmid:19280525
Ward KW et al. Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human. 2005 Xenobiotica pmid:16019946
Molnari JC and Myers AL Carbonyl reduction of bupropion in human liver. 2012 Xenobiotica pmid:22339467
Kaye B and Roberts DW The metabolism of oxamniquine in the gut wall. 1980 Xenobiotica pmid:7395269
Watanabe M et al. Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. 1999 Xenobiotica pmid:10553724
Kubo JI et al. Pharmacokinetic evaluation of high pulmonary disposition of clarithromycin after systemic administration. 2002 Xenobiotica pmid:12419017
Trepanier LA and Miller JL NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes. 2000 Xenobiotica pmid:11307968
Guillouzo A et al. Human hepatocyte cultures: a model of pharmaco-toxicological studies. 1985 Aug-Sep Xenobiotica pmid:3907158
Kanazu T et al. Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. I: evaluation of cynomolgus monkeys as surrogates for humans. 2004 Xenobiotica pmid:15370956
Zhang Y et al. [Erythromycin restores oxidative stress-induced corticosteroid responsiveness of human THP-1 cells by up-regulating the expression of histone deacetylase 2]. 2014 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:24721407
Watanabe Y et al. [Relationship between quality and serum level after the oral administration of commercial erythromycin tablets in man (author's transl)]. 1977 Yakugaku Zasshi pmid:911413
Matsuoka M [Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus]. 2000 Yakugaku Zasshi pmid:10774259
Nakamura H et al. Effect of particle size on mixing degree in dispensation. 2004 Yakugaku Zasshi pmid:15049131
Nakamura H et al. Effect of mixing method on the mixing degree during the preparation of triturations. 2004 Yakugaku Zasshi pmid:15049130
Watanabe Y et al. [Effect of dissolving pH of enteric coating agent on bioavailability of enteric coated tablets of erythromycin in man (author's transl)]. 1978 Yakugaku Zasshi pmid:30834
Miyazaki M et al. [Trends and antimicrobial susceptibilities of clinical methicillin-resistant Staphylococcus aureus isolates in Fukuoka University Chikushi Hospital 2008-2012]. 2014 Yakugaku Zasshi pmid:24492229
Otsuka M et al. [Studies on fungicides. XIV. Effect of erythromycin on the growth of fungal mycelia (author's transl)]. 1978 Yakugaku Zasshi pmid:566318
Xu P et al. [Synthesis of derivatives of (9S) -9-hydroxyl-12-methylene erythromycin A and their antibacterial activity in vitro]. 2007 Yao Xue Xue Bao pmid:17703771
Chen HX et al. [Compound erythromycin sustained release preparation and its in vitro release]. 2011 Yao Xue Xue Bao pmid:22260035